Company / Working Capital per Share
Cue Biopharma, Inc. Working Capital per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$0.38
FY2025
5-year range
$0.24 / $2.04
FY2021-FY2025
Trend
+56.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Working Capital per Share returned to growth in FY2025 after 2 years of decline, reaching $0.38.
Based on SEC 10-K filings.
0.38 in FY2025 with a 5-year CAGR of -32.3%.
Declined from $0.73 to $0.38 over the past 2 years.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -42.9%
- 5-Year CAGR
- -32.3%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, working capital per share increased 56.7% year-over-year.
- Peak working capital per share was recorded in FY2020.
- Lowest working capital per share in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -7.60 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.38 | +56.7% |
| FY2024 | $0.24 | -66.7% |
| FY2023 | $0.73 | -64.3% |
| FY2022 | $2.04 | +11.1% |
| FY2021 | $1.83 | -31.6% |
| FY2020 | $2.68 | +12.4% |
| FY2019 | $2.39 | +35.0% |
| FY2018 | $1.77 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026